ENTITY
CanariaBio

CanariaBio (016790 KS)

21
Analysis
Consumer StaplesSouth Korea
CANARIABIO Inc. operates as a new anticancer drugs development biotechnology company. The Company develops ovarian cancer, pancreatic cancer, gynecological cancer, and metastatic breast cancer immunotherapy drugs. CANARIABIO also produces sheep, pig, hog, poultry, and sweetened feed products.
more
16 Nov 2022 12:52

KOSPI 200 & KOSDAQ 150 Rebalance Changes + KOSPI 200 & KOSDAQ 150 Exclusion Candidates in 2023

Korea Exchange announced the KOSPI 200, KOSDAQ 150, and KRX 300 rebalance changes today. Lotte Confectionery will be added and Samyang Holdings...

Logo
842 Views
Share
bearishHPSP
07 Nov 2022 17:56

Shorting Setup on Additions to KS200/KQ150 with KODEX Battery ETF Flow

This post examines the shorting situation of the KS200/KQ150 additions in the upcoming rebalancing with the potentially mitigating flow from the...

Logo
233 Views
Share
bullishHPSP
31 Oct 2022 20:40

KOSDAQ150 Index Rebalance Preview: Big Churn in IT, Healthcare Stocks

There could be 11 changes at the Dec rebalance. Most changes are high probability and will result in a big churn in the IT & Healthcare sectors....

Logo
426 Views
Share
bullishISC Co Ltd
06 Oct 2022 22:53

KOSDAQ150 Index Rebalance Preview: Moving in the Right Direction

There could be 10 changes to the KOSDAQ150 Index in December. There are a few stocks that are close adds/deletes. The potential adds have...

Logo
476 Views
Share
bullishCanariaBio
05 Oct 2022 02:32

KOSDAQ 150 Rebalancing: 7 Regular Changes + 2 Special Entries

KOSDAQ 150 rebalancing in December will feature 7 regular changes and 2 special entries. This post details the screening results and the resulting...

Logo
470 Views
Share
x